[Federal Register: January 11, 2001 (Volume 66, Number 8)]
[Notices]
[Page 2437]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr11ja01-86]
[[Page 2437]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases;
Notice of Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. appendix 2), notice is hereby given of meetings of
the National Diabetes and Digestive and Kidney Diseases Advisory
Council.
The meetings will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation of
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Diabetes and Digestive and Kidney
Diseases Advisory Council.
Date: February 7-8, 2001.
Open: February 7, 2001, 8:30 AM to 12:00 PM.
Agenda: Present the Director's Report and other scientific
presentations.
Place: National Institutes of Health, 9000 Rockville Pike,
Building 31, Conference Room 10, Bethesda, MD 20892.
Closed: February 7, 2001, 2:30 PM to adjournment.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 9000 Rockville Pike,
Building 31, Conference Room 10, Bethesda, MD 20892.
Closed: February 8, 2001, 9:45 AM to 10:15 AM.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 9000 Rockville Pike,
Building 31, Conference Room 10, Bethesda, MD 20892.
Open: February 8, 2001, 10:15 AM to 12:00 PM.
Agenda: Present the Director's Report and other scientific
presentations.
Place: National Institutes of Health, 9000 Rockville Pike,
Building 31, Conference Room 10, Bethesda, MD 20892.
Contact Person: Robert D. Hammond, PhD, Director For Extramural
Activities, National Institute of Diabetes and Digestive and Kidney
Diseases, National Institutes of Health, 6707 Democracy Blvd, Room
631, MSC 5452, Bethesda, MD 20892-5452, 301-594-8834, rh53k@nih.gov
Name of Committee: National Diabetes and Digestive and Kidney
Diseases Advisory Council, Digestive Diseases and Nutrition
Subcommittee.
Date: February 7-8, 2001.
Open: February 7, 2001, 1:30 PM to 2:30 PM.
Agenda: Review of the Division's scientific and planning
activities.
Place: National Institutes of Health, 9000 Rockville Pike,
Building 31A, Conference Room 9A51, Bethesda, MD 20892.
Closed: February 7, 2001, 2:30 PM to adjournment.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 9000 Rockville Pike,
Building 31A, Conference Room 9A51, Bethesda, MD 20892.
Closed: February 8, 2001, 8:00 AM to 9:30 AM.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 9000 Rockville Pike,
Building 31A, Conference Room 9A51, Bethesda, MD 20892.
Contact Person: Robert D. Hammond, PhD, Director for Extramural
Activities, National Institute of Diabetes and Digestive and Kidney
Diseases, National Institutes of Health, 6707 Democracy Blvd, Room
631, MSC 5452, Bethesda, MD 20892-5452, 301-594-8834, rh53k@nih.gov
Name of Committee: National Diabetes and Digestive and Kidney
Diseases Advisory Council, Endocrine and Metabolic Diseases
Subcommittee.
Date: February 7-8, 2001.
Open: February 7, 2001, 1:30 PM to 2:30 PM.
Agenda: Review of the Division's scientific and planning
activities.
Place: National Institutes of Health, 9000 Rockville Pike,
Building 31, Conference Room 10, Bethesda, MD 20892.
Closed: February 7, 2001, 2:30 PM to adjournment.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 9000 Rockville Pike,
Building 31, Conference Room 10, Bethesda, MD 20892.
Closed: February 8, 2001, 8:00 AM to 9:30 AM.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 9000 Rockville Pike,
Building 31, Conference Room 10, Bethesda, MD 20892.
Contact Person: Robert D. Hammond, PhD, Director for Extramural
Activities, National Institute of Diabetes and Digestive and Kidney
Diseases, National Institutes of Health, 6707 Democracy Blvd, Room
631, MSC 5452, Bethesda, MD 20892-5452, 301-594-8834, rh53k@nih.gov
Name of Committee: National Diabetes and Digestive and Kidney
Diseases Advisory Council, Kidney, Urologic and Hematologic Diseases
Subcommittee.
Date: February 7-8, 2001.
Open: February 7, 2001, 1:30 PM to 2:30 PM.
Agenda: Review of the Division's scientific and planning
activities.
Place: National Institutes of Health, 9000 Rockville Pike,
Building 31C, Conference Room 7, Bethesda, MD 20892.
Closed: February 7, 2001, 2:30 PM to adjournment.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 9000 Rockville Pike,
Building 31C, Conference Room 7, Bethesda, MD 20892.
Closed: February 8, 2001, 8:00 AM to 9:30 AM.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 9000 Rockville Pike,
Building 31C, Conference Room 7, Bethesda, MD 20892.
Contact Person: Robert D. Hammond, PhD, Director for Extramural
Activities, National Institute of Diabetes and Digestive and Kidney
Diseases, National Institutes of Health, 6707 Democracy Blvd, Room
631, MSC 5452, Bethesda, MD 20892-5452, 301-594-8834, rh53k@nih.gov
(Catalogue of Federal Domestic Assistance Program Nos. 93.847,
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes of Health, HHS)
Dated: January 4, 2001.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 01-809 Filed 1-10-01; 8:45 am]
BILLING CODE 4140-01-M